3-[(Imidazolidin-2-yl)imino]indazole ligands with selectivity for the α(2)-adrenoceptor compared to the imidazoline I(1) receptor.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Bioorganic & Medicinal Chemistry

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bmc.2010.11.020PMID 21129985
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 1-[(Imidazolidin-2-yl)imino]indazole. Highly alpha 2/I1 selective agonist: synthesis, X-ray structure, and biological activity.

  2008cited by this paper
• Alpha2-adrenoceptor agonists.

  2007cited by this paper
• New practical synthesis of indazoles via condensation of o-fluorobenzaldehydes and their O-methyloximes with hydrazine.

  2006cited by this paper
• Calcimimetic NPS R-568 induces hypotensive effect in spontaneously hypertensive rats.

  2005cited by this paper
• Aminopiperidine indazoles as orally efficacious melanin concentrating hormone receptor-1 antagonists.

  2005cited by this paper
• Ligand-induced alpha2-adrenoceptor endocytosis: relationship to Gi protein activation.

  2004cited by this paper
• Physiological significance of alpha(2)-adrenergic receptor subtype diversity: one receptor is not enough.

  2002cited by this paper
• Imidazoline antihypertensive drugs: a critical review on their mechanism of action.

  2002cited by this paper
• I1 receptors, cardiovascular function, and metabolism.

  2001cited by this paper
• A novel method for the efficient synthesis of 2-arylamino-2-imidazolines

  2000cited by this paper
• Simplified Synthesis of the Precursor for the Azo Dye Chlorindazone DS

  2000cited by this paper
• Cardiovascular effects of rilmenidine, moxonidine and clonidine in conscious wild‐type and D79N α2A‐adrenoceptor transgenic mice

  1999cited by this paper
• Alpha‐2 and imidazoline receptor agonistsTheir pharmacology and therapeutic role

  1999cited by this paper
• Subtype-specific stimulation of [35S]GTPgammaS binding by recombinant alpha2-adrenoceptors.

  1998cited by this paper
• Subtype-specific stimulation of []GTPγS binding by recombinant α2-adrenoceptors

  1998cited by this paper
• Characterisation and localisation of [3H]2-(2-benzofuranyl)-2-imidazoline binding in rat brain: a selective ligand for imidazoline I2 receptors.

  1998cited by this paper
• Central imidazoline receptors and centrally acting anti-hypertensive agents.

  1997cited by this paper
• Identification of ligands selective for central I2-imidazoline binding sites.

  1997cited by this paper
• Central hypotensive effects of the alpha2a-adrenergic receptor subtype.

  1996cited by this paper
• Central Hypotensive Effects of the α2a-Adrenergic Receptor Subtype

  1996cited by this paper
• I1‐Imidazoline Receptors

  1995cited by this paper
• I1-imidazoline receptors. Definition, characterization, distribution, and transmembrane signaling.

  1995cited by this paper
• Functional Studies of Specific Imidazoline‐2 Receptor Ligands

  1995cited by this paper
• Pharmacologic and therapeutic applications of alpha 2-adrenoceptor subtypes.

  1993cited by this paper
• Centrally Acting Drugs (Clonidine, Methyldopa, Guanfacine)

  1990cited by this paper
• Pharmacology of the alpha2-adrenoceptor agonist rilmenidine

  1988cited by this paper
• Pharmacology of the alpha 2-adrenoceptor agonist rilmenidine.

  1988cited by this paper
• Unique presynaptic alpha 2-receptor selectivity and specificity of the antihypertensive agent moxonidine.

  1988cited by this paper
• Rudolf Buchheim lecture. Drugs as tools in research on adrenoceptors.

  1986cited by this paper
• Drugs as tools in research on adrenoceptors

  1986cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper
• Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

  1973cited by this paper

• Copper-Catalyzed Denitrogenative Radical Cyclization of 3-Aminoindazoles with o-Cyanoarylacrylamides: Synthesis of Cyanoarylated Quinoline-2,4(1H,3H)-diones.

  2025cites this paper
• Structure-based discovery of CFTR potentiators and inhibitors.

  2024cites this paper
• Structure-based discovery of CFTR potentiators and inhibitors

  2023cites this paper
• Antihypertensive activity of indole and indazole analogues: a review

  2022cites this paper
• Indazole and its derivatives in cardiovascular diseases: Overview, current scenario and future perspectives.

  2021cites this paper
• Ligand- and Structure-Based Analysis of Deep Learning-Generated Potential α2a Adrenoceptor Agonists

  2021cites this paper
• Cardiovascular Effects Mediated by Imidazoline Drugs: an Update.

  2019cites this paper
• Palladium-catalyzed direct C–H nitration and intramolecular C–H functionalization for the synthesis of 3-nitro-1-(phenylsulfonyl)-1H-indazole derivatives

  2019cites this paper
• NEW CARBAMATES OF 1-(4-NITROPHENYL)PIPERAZINE AND BIS CARBAMATES OF 6-AMINOINDAZOLE: DESIGN, SYNTHESIS, CHARACTERIZATION, MOLECULAR DOCKING STUDIES AND BIOACTIVITY EVALUATION

  2018cites this paper
• 1‐[(Imidazolidin‐2‐yl)imino]‐1H‐indoles as new hypotensive agents: synthesis and in vitro and in vivo biological studies

  2017cites this paper
• Are Alpha-2D Adrenoceptor Subtypes Involved in Rat Mydriasis Evoked by New Imidazoline Derivatives: Marsanidine and 7-Methylmarsanidine?

  2017cites this paper
• Synthesis and Preliminary Cytotoxicity Studies of 1-[1-(4,5-Dihydrooxazol- 2-yl)-1H-indazol-3-yl]-3-phenylurea and 3-phenylthiourea Derivatives.

  2017cites this paper
• Comparative pharmacodynamic analysis of imidazoline compounds using rat model of ocular mydriasis with a test of quantitative structure–activity relationships

  2017cites this paper
• Transfer of SAR information from hypotensive indazole to indole derivatives acting at α-adrenergic receptors: In vitro and in vivo studies.

  2016cites this paper
• Imidazoline scaffold in medicinal chemistry: a patent review (2012–2015)

  2016cites this paper
• 1-[(IMIDAZOLIN-2-YL)AMINO]INDOLINE AND 1-[(IMIDAZOLIN-2 YL)AMINO] 1,2,3,4-TETRAHYDROQUINOLINE DERIVATIVES: NEW INSIGHTS INTO THEIR CIRCULATORY ACTIVITIES.

  2015cites this paper
• Synthesis of indazole motifs and their medicinal importance: an overview.

  2015cites this paper
• Synthesis and biological evaluation of 2-aryliminopyrrolidines as selective ligands for I1 imidazoline receptors: discovery of new sympatho-inhibitory hypotensive agents with potential beneficial effects in metabolic syndrome.

  2015cites this paper
• The effect of 7-fluoro-marsanidine, a novel α2-adrenoceptor agonist, on extracellular noradrenaline in rat frontal cortex: a microdialysis study.

  2015cites this paper
• Analysis of Small Molecule X-Ray Crystal Structures: Chemical Crystallography with Undergraduate Students in a Teaching Laboratory

  2014cites this paper
• Fluorinated analogues of marsanidine, a highly α2-AR/imidazoline I1 binding site-selective hypotensive agent. Synthesis and biological activities.

  2014cites this paper
• Synthesis and biological activities of 2-[(heteroaryl)methyl]imidazolines.

  2012cites this paper
• Synthesis, Structure of Zwitterionic 2‐Amino‐N′‐(imidazolidin‐2‐ylidene)benzohydrazides, and Their Transformation into 3‐(Imidazolidin‐2‐ylideneamino)quinazolin‐4(1H)‐one Derivatives

  2012cites this paper
• Tizanidine and tizanidine hydrochloride: on the correct tautomeric form of tizanidine.

  2012cites this paper